Company Filing History:
Years Active: 1991
Title: Jurgen Schnur: Innovator in Dialyzer Technology
Introduction
Jurgen Schnur is a notable inventor based in Oberthal, Germany. He has made significant contributions to the field of medical technology, particularly in the design of closure caps for dialyzers. His innovative approach has led to the development of a patent that enhances the sterilization process of medical devices.
Latest Patents
Jurgen Schnur holds a patent for a closure cap designed specifically for dialyzers. This invention relates to a closure cap that is suitable for in-line sterilization. The closure cap comprises two parts, where the first part is mounted on a dialyzer flange, and the second part is movable within the first part. This design allows for the passage of sterilization medium in the open position, ensuring that all components can be reliably sterilized. In the closure position, the second part seals the first part, preventing contamination after the dialyzer is removed from the sterilization apparatus. This patent showcases his commitment to improving medical device safety and efficacy.
Career Highlights
Jurgen Schnur is associated with Fresenius AG, a leading company in the healthcare sector. His work at Fresenius AG has allowed him to focus on innovations that directly impact patient care and medical technology. With a patent count of 1 patent, he has established himself as a valuable contributor to the field.
Collaborations
Throughout his career, Jurgen has collaborated with talented professionals, including Bernd Mathieu and Michael Rinck. These collaborations have fostered an environment of innovation and creativity, leading to advancements in medical technology.
Conclusion
Jurgen Schnur's contributions to the field of dialyzer technology exemplify the importance of innovation in healthcare. His patented closure cap design not only enhances sterilization processes but also ensures patient safety. His work at Fresenius AG and collaborations with other professionals further highlight his commitment to advancing medical technology.